Expanding Access to Long-Acting ART in Europe
In this episode, Stephane De Wit, MD, PhD, discusses the benefits of long-acting antiretroviral therapy (ART) for migrant populations in Europe—and specifically in Belgium. He also addresses some of t...
19 Joulu 202211min
Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?
When it comes to managing adults with HBV, should age factor into your treatment decision—or is it important to treat everyone, regardless of age?Listen as Dr George Lau discusses these questions and ...
15 Joulu 202212min
Whom to Screen for Hepatitis Delta Virus
In this episode, Nancy Reau, MD, and Coleman I. Smith, MD, discuss the burden of undiagnosed hepatitis delta virus (HDV) infection and who should be tested, including:Epidemiology of HDV infectionClin...
15 Joulu 202213min
What Patients Want in HIV Treatment and Prevention: Africa
In this episode, Winnie Sseruma and Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discuss some of the barriers to genuinely patient-centered HIV care in Africa and offer calls to action for heal...
14 Joulu 202233min
What Patients Want in HIV Treatment and Prevention: Malaysia
In this episode, Iskandar Azwa, MBChB, and patient advocate Andrew Tan Tze Tho discuss barriers to genuinely patient-centered HIV care in Malaysia and the surrounding region and offer calls to action ...
7 Joulu 202237min
Addressing ART Safety and Tolerability in Transgender Individuals
In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including:Strategies on ...
7 Joulu 202218min
FAQs: Improving Empiric Antibiotic Regimens for HABP/VABP in the ICU
In this episode, Marion Elligsen, BScPhm, MSc, RPh, ACPR; Keith S Kaye, MD, MPH; and Andrew Shorr, MD, MPH, MBA, discuss key considerations for selecting empiric antibiotic regimens in patients with H...
6 Joulu 202230min
Practice-Changing Viral Hepatitis Data From AASLD 2022
In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:Novel therapeutics for HBVHCV management strategiesHDV screening and ...
6 Joulu 20228min
